Refractory Skin Ulcer
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Clinical Study of PAL-222 Targeting Patients With Refractory Skin Ulcer (NCT07016438) | PharmaBio Corporation | 2025-04-15 |
Track Refractory Skin Ulcer automatically
Every clearance here is in the API, with alerts when new ones post.